![Peter Moran](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Peter Moran
Gründer bei Singular ID Pte Ltd.
Profil
Peter Moran is Chief Technology Officer and a Director Singular ID Pte Ltd.
Previously, he was a Senior Scientist of IMRE.
Dr. Morean received a PhD in Engineering and an MS degree in Applied Mathematics and Engineering from Brown University.
Aktive Positionen von Peter Moran
Unternehmen | Position | Beginn |
---|---|---|
Singular ID Pte Ltd.
![]() Singular ID Pte Ltd. Packaged SoftwareTechnology Services Singular ID Pte Ltd. manufactures and supplies security systems and products. The company was founded in December 2004 and is headquartered in Singapore. | Gründer | - |
Ehemalige bekannte Positionen von Peter Moran
Unternehmen | Position | Ende |
---|---|---|
Cypress Bioscience, Inc.
![]() Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Corporate Officer/Principal | - |
Ausbildung von Peter Moran
Brown University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Singular ID Pte Ltd.
![]() Singular ID Pte Ltd. Packaged SoftwareTechnology Services Singular ID Pte Ltd. manufactures and supplies security systems and products. The company was founded in December 2004 and is headquartered in Singapore. | Technology Services |
Cypress Bioscience, Inc.
![]() Cypress Bioscience, Inc. BiotechnologyHealth Technology Cypress Bioscience, Inc. develops drug therapies for Functional Somatic Syndromes, rheumatoid conditions that often cause sufferers chronic pain. The company provides medicine for Fibromyalgia Syndrome, a condition marked by painful stiffness, headaches and fatigue that affects approximately 5% of the world's population. The company was founded in 1981 and is located in San Diego, CA. | Health Technology |